| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 5 |
| 1 | BEVACIZUMAB | 4 |
| 2 | FUROSEMIDE | 4 |
| 3 | GEMCITABINE HYDROCHLORIDE | 4 |
| 4 | CAPECITABINE | 3 |
| 5 | ERLOTINIB HYDROCHLORIDE | 3 |
| 6 | CITALOPRAM | 2 |
| 7 | DENOSUMAB | 2 |
| 8 | EXENATIDE | 2 |
| 9 | GEMCITABINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 1 | TRIMIPRAMINE | 1 | 0.0009 |
| 2 | IVOSIDENIB | 1 | 0.0005 |
| 3 | LANTHANUM CARBONATE | 2 | 0.0004 |
| 4 | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0003 |
| 5 | MEGESTROL ACETATE | 1 | 0.0003 |
| 6 | ERLOTINIB HYDROCHLORIDE | 3 | 0.0002 |
| 7 | TREMELIMUMAB | 1 | 0.0002 |
| 8 | PALONOSETRON HYDROCHLORIDE | 1 | 0.0002 |
| 9 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 1 | Cannabinoid [EPC] | 1 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |